{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:51:52Z","timestamp":1789012312935,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.brachy.2025.10.009","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T12:29:17Z","timestamp":1769257757000},"page":"539-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of radiation dosage to vital ocular structures on visual outcomes: Re-evaluation for the future"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4169-0568","authenticated-orcid":false,"given":"Lauren B","family":"Yeager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Tsamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bompastore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5096-1147","authenticated-orcid":false,"given":"Yujia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1977-8616","authenticated-orcid":false,"given":"Joseph","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8812-5083","authenticated-orcid":false,"given":"Israel","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P","family":"Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2025.10.009_bib0001","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archopht.119.7.969","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS report No. 18","volume":"119","author":"Diener-West","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2025.10.009_bib0002","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000455872","article-title":"Iodine-125 brachytherapy for uveal melanoma: a systematic review of radiation dose","volume":"3","author":"Echegaray","year":"2017","journal-title":"Ocular Oncol Pathol"},{"key":"10.1016\/j.brachy.2025.10.009_bib0003","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bjo.50.3.147","article-title":"Radiotherapy for malignant melanoma of the choroid","volume":"50","author":"Stallard","year":"1966","journal-title":"British J Ophthalmol"},{"key":"10.1016\/j.brachy.2025.10.009_bib0004","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/archopht.119.7.1067","article-title":"Fifteen years of work: the COMS outcomes for medium size choroidal melanoma","volume":"119","author":"Sieving","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2025.10.009_bib0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0002-9394(03)00265-4","article-title":"Changing concepts in the management of choroidal melanoma","volume":"136","author":"Roberston","year":"2003","journal-title":"Am J ophthal"},{"issue":"3","key":"10.1016\/j.brachy.2025.10.009_bib0006","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000480640","article-title":"Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013)","volume":"4","author":"Aronow","year":"2018","journal-title":"Ocul Oncol Pathol"},{"issue":"9","key":"10.1016\/j.brachy.2025.10.009_bib0007","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal Melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.brachy.2025.10.009_bib0008","first-page":"1","article-title":"American Brachytherapy Society- Ophthalmic Oncology Task Force. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.10.009_bib0009","unstructured":"Eye physics. Available at: http:\/\/www.eyephysics.com\/ (accessed date 1\/4\/2025)."},{"key":"10.1016\/j.brachy.2025.10.009_bib0010","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0360-3016(97)00118-1","article-title":"Conformal episcleral plaque therapy","volume":"39","author":"Astrahan","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.brachy.2025.10.009_bib0011","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","article-title":"Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16","volume":"108","author":"Melia","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2025.10.009_bib0012","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/eye.2009.43","article-title":"Ocular complications following I- 125 brachytherapy for choroidal melanoma","volume":"23","author":"Wen","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.brachy.2025.10.009_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijrobp.2014.01.026","article-title":"Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes","volume":"89","author":"Perez","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.10.009_bib0014","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1167\/iovs.04-0066","article-title":"Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques","volume":"45","author":"Puusaari","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.brachy.2025.10.009_bib0015","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1442-9071.2005.01067.x","article-title":"New Zealand experience ofI125 brachytherapy for choroidal melanoma","volume":"33","author":"Stack","year":"2005","journal-title":"Clin Exp Ophthalm ol"},{"key":"10.1016\/j.brachy.2025.10.009_bib0016","doi-asserted-by":"crossref","first-page":"619e623","DOI":"10.1016\/0360-3016(93)90278-4","article-title":"Treatment of choroidal melanoma with I-125 plaque","volume":"26","author":"Fontanesi","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.10.009_bib0017","doi-asserted-by":"crossref","first-page":"763e764","DOI":"10.1001\/archopht.1987.01060060049030","article-title":"Selection of iodine 125 for the Collaborative Ocular Melanoma Study","volume":"105","author":"Earle","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2025.10.009_bib0018","doi-asserted-by":"crossref","first-page":"1855e1861","DOI":"10.1016\/S0161-6420(02)01273-3","article-title":"Iodine-125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas","volume":"109","author":"Bechrakis","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2025.10.009_bib0019","first-page":"1838e1849","article-title":"Plaque radiotherapy for large posterior uveal melanomas (>or\u202f=\u202fto 8-mm thick) in 354 consecutive patients","volume":"109","author":"Shields","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2025.10.009_bib0020","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0161-6420(03)00661-4","article-title":"Iodine brachytherapy as an alternative to enucleation for large uveal melanomas","volume":"110","author":"Puusaari","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2025.10.009_bib0021","doi-asserted-by":"crossref","first-page":"392e400","DOI":"10.1016\/j.ijrobp.2005.02.059","article-title":"Visual acuity after ruthenium-106 brachytherapy of choroidal melanomas","volume":"63","author":"Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.10.009_bib0022","doi-asserted-by":"crossref","first-page":"790e796","DOI":"10.1016\/j.ophtha.2008.12.027","article-title":"Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients","volume":"116","author":"Finger","year":"2009","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.brachy.2025.10.009_bib0023","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.brachy.2018.07.002","article-title":"Outcomes of choroidal melanomas treated with eye physics plaques: a 25-year review","volume":"17","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.10.009_bib0024","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0360-3016(97)00118-1","article-title":"Conformal episcleral plaque therapy","volume":"39","author":"Astrahan","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.10.009_bib0025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jamaophthalmol.2016.0104","article-title":"Vision loss following episcleral brachytherapy for uveal melanoma: development of a vision prognostication tool","volume":"134","author":"Aziz","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.brachy.2025.10.009_bib0026","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0360-3016(93)90277-3","article-title":"High intensity 125-iodine (125I) plaque treatment of uveal melanoma","volume":"26","author":"Quivey","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.10.009_bib0027","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ajo.2009.11.006","article-title":"Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma","volume":"149","author":"Finger","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2025.10.009_bib0028","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/archophthalmol.2011.161","article-title":"Subfoveal choroidal melanoma: pre-treatment characteristics and response to plaque radiation therapy","volume":"129","author":"Newman","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.brachy.2025.10.009_bib0029","first-page":"61","article-title":"Brachytherapy of choroidal melanomas","volume":"168","author":"Brady","year":"1992","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2025.10.009_bib0030","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.118.6.773","article-title":"A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma","volume":"118","author":"Gragoudas","year":"2000","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.brachy.2025.10.009_bib0031","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiot Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.10.009_bib0032","first-page":"1226","article-title":"Radiation dose-volume effects of optic nerves and chiasm","volume":"84","author":"Mayo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.10.009_bib0033","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2010.02.051","article-title":"Risk factors for cataract following palladium-103 ophthalmic plaque radiation therapy","volume":"80","author":"Finger","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.brachy.2025.10.009_bib0034","article-title":"Preliminary results of uveal melanoma treated with iodine-125 plaques: analysis of disease control and visual outcomes with 63 gy to the target volume","volume":"7","author":"Kheir","year":"2022","journal-title":"Adv Radiat Oncol"},{"issue":"6","key":"10.1016\/j.brachy.2025.10.009_bib0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0161-6420(89)32806-5","article-title":"Reasons for enucleation after plaque radiotherapy for posterior uveal melanoma. Clinical findings","volume":"96","author":"Shields","year":"1989","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.brachy.2025.10.009_bib0036","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ophtha.2010.06.007","article-title":"Plaque radiotherapy for juxtapapillary choroidal melanoma: tumor control in 650 consecutive cases","volume":"118","author":"Sagoo","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2025.10.009_bib0037","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.118.6.773","article-title":"A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma","volume":"118","author":"Gragoudas","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2025.10.009_bib0038","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ijrobp.2009.08.059","article-title":"Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study","volume":"78","author":"Saconn","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.10.009_bib0039","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5114\/jcb.2016.57818","article-title":"Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rate","volume":"1","author":"Naseripour","year":"2016","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2025.10.009_bib0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijrobp.2008.10.077","article-title":"Dose de-escalation with gamma knife radiosurgery in the treatment of choroidal melanoma","volume":"75","author":"Schirmer","year":"2009","journal-title":"Int J Radiat Oncol"},{"issue":"11","key":"10.1016\/j.brachy.2025.10.009_bib0041","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/eye.2012.158","article-title":"The effects of intraocular silicone oil placement prior to iodine 125 brachytherapy for uveal melanoma: a clinical case series","volume":"26","author":"Ahuja","year":"2012","journal-title":"Eye (Lond)"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125003538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125003538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:43:05Z","timestamp":1776814985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125003538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1538472125003538"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2025.10.009","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of radiation dosage to vital ocular structures on visual outcomes: Re-evaluation for the future","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2025.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}